Rapt Therapeutics Inc (RAPT)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: RAPT Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-01-08 2024-01-05 PS Planned sale

Brockstedt Dirk G.

CHIEF SCIENTIFIC OFFICER

Officer
898 -3.1%
22.78
20,456 USD 		898 -3.1% 22.78 20,456 USD
2023-12-22 2023-12-21 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
2,500 -14.3%
21.68
54,200 USD 		2,500 -14.3% 21.68 54,200 USD
2023-11-29 2023-11-28 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,500 -7.9%
13.72
20,580 USD 		1,500 -7.9% 13.72 20,580 USD
2023-10-04 2023-10-03 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
2,500 -11.7%
15.77
39,425 USD 		2,500 -11.7% 15.77 39,425 USD
2023-08-22 2023-08-18 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
2,500 -10.5%
18.92
47,300 USD 		2,500 -10.5% 18.92 47,300 USD
2023-04-20 2023-04-19 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
5,000 -19.2%
18.88
94,400 USD 		5,000 -19.2% 18.88 94,400 USD
2023-03-15 2023-03-14 B Purchase

Robbins Wendye

Non-Executive Director
2,500 +62.5%
20.05
50,125 USD 		2,500 +62.5% 20.05 50,125 USD
2023-03-15 2023-03-14 B Purchase

Robbins Wendye

Non-Executive Director
600 +4.2%
19.95
11,970 USD 		600 +4.2% 19.95 11,970 USD
2023-03-15 2023-03-14 B Purchase

Robbins Wendye

Non-Executive Director
400 +2.9%
18.48
7,392 USD 		400 +2.9% 18.48 7,392 USD
2023-03-15 2023-03-14 B Purchase

Robbins Wendye

Non-Executive Director
1,500 +12.1%
18.75
28,125 USD 		1,500 +12.1% 18.75 28,125 USD
2023-03-13 2023-03-07 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
5,000 -16.4%
29.62
148,100 USD 		5,000 -16.4% 29.62 148,100 USD
2023-01-26 2023-01-24 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
5,000 -14.3%
30.00
150,000 USD 		5,000 -14.3% 30.00 150,000 USD
2023-01-20 2023-01-19 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
5,000 -12.5%
25.56
127,800 USD 		5,000 -12.5% 25.56 127,800 USD
2023-01-09 2023-01-05 S Sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
742 -3.7%
21.97
16,299 USD 		742 -3.7% 21.97 16,299 USD
2022-12-30 2022-12-29 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
5,000 -11.7%
18.03
90,150 USD 		5,000 -11.7% 18.03 90,150 USD
2022-11-29 2022-11-28 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
5,000 -10.5%
17.87
89,350 USD 		5,000 -10.5% 17.87 89,350 USD
2022-11-03 2022-11-02 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
5,000 -9.5%
22.32
111,600 USD 		5,000 -9.5% 22.32 111,600 USD
2022-10-14 2022-10-13 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
2,000 -3.7%
21.52
43,040 USD 		2,000 -3.7% 21.52 43,040 USD
2022-08-31 2022-08-30 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
2,500 -4.5%
28.13
70,325 USD 		2,500 -4.5% 28.13 70,325 USD
2022-07-13 2022-07-11 S Sale

HO WILLIAM

Chief Medical Officer

Officer
2,000 -3.7%
19.95
39,900 USD 		2,000 -3.7% 19.95 39,900 USD
2022-05-27 2022-05-25 B Purchase

COLUMN GROUP II, LP

Major owner
63 +0.1%
12.45
785 USD 		63 +0.1% 12.45 785 USD
2022-05-27 2022-05-25 B Purchase

COLUMN GROUP II, LP

Major owner
1,837 +0.1%
12.45
22,880 USD 		1,837 +0.1% 12.45 22,880 USD
2022-05-27 2022-05-25 B Purchase

COLUMN GROUP II, LP

Major owner
63 +0.1%
12.45
785 USD 		63 +0.1% 12.45 785 USD
2022-05-27 2022-05-25 B Purchase

COLUMN GROUP II, LP

Major owner
1,837 +0.1%
12.45
22,880 USD 		1,837 +0.1% 12.45 22,880 USD
2022-05-25 2022-05-24 B Purchase

COLUMN GROUP II, LP

Major owner
538 +1.3%
12.00
6,457 USD 		538 +1.3% 12.00 6,457 USD
2022-05-25 2022-05-24 B Purchase

COLUMN GROUP II, LP

Major owner
15,776 +1.3%
12.00
189,345 USD 		15,776 +1.3% 12.00 189,345 USD
2022-05-25 2022-05-24 B Purchase

COLUMN GROUP II, LP

Major owner
538 +1.3%
12.00
6,457 USD 		538 +1.3% 12.00 6,457 USD
2022-05-25 2022-05-24 B Purchase

COLUMN GROUP II, LP

Major owner
15,776 +1.3%
12.00
189,345 USD 		15,776 +1.3% 12.00 189,345 USD
2022-05-25 2022-05-23 B Purchase

COLUMN GROUP II, LP

Major owner
338 +0.8%
12.50
4,225 USD 		338 +0.8% 12.50 4,225 USD
2022-05-25 2022-05-23 B Purchase

COLUMN GROUP II, LP

Major owner
9,898 +0.8%
12.50
123,718 USD 		9,898 +0.8% 12.50 123,718 USD
2022-05-25 2022-05-23 B Purchase

COLUMN GROUP II, LP

Major owner
338 +0.8%
12.50
4,225 USD 		338 +0.8% 12.50 4,225 USD
2022-05-25 2022-05-23 B Purchase

COLUMN GROUP II, LP

Major owner
9,898 +0.8%
12.50
123,718 USD 		9,898 +0.8% 12.50 123,718 USD
2022-05-12 2022-05-10 B Purchase

COLUMN GROUP II, LP

Major owner
41,250 +inf%
10.67
440,199 USD 		41,250 +inf% 10.67 440,199 USD
2022-05-12 2022-05-10 B Purchase

COLUMN GROUP II, LP

Major owner
1,208,750 +inf%
10.67
12,899,176 USD 		1,208,750 +inf% 10.67 12,899,176 USD
2022-05-12 2022-05-10 B Purchase

Robbins Wendye

Non-Executive Director
400 +11.1%
10.62
4,248 USD 		400 +11.1% 10.62 4,248 USD
2022-05-12 2022-05-10 B Purchase

Robbins Wendye

Non-Executive Director
600 +20.0%
10.49
6,294 USD 		600 +20.0% 10.49 6,294 USD
2022-05-12 2022-05-10 B Purchase

Robbins Wendye

Non-Executive Director
1,000 +50.0%
10.51
10,510 USD 		1,000 +50.0% 10.51 10,510 USD
2022-05-12 2022-05-10 B Purchase

Robbins Wendye

Non-Executive Director
500 +38.5%
11.30
5,650 USD 		500 +38.5% 11.30 5,650 USD
2022-05-12 2022-05-10 B Purchase

Robbins Wendye

Non-Executive Director
2,500 +22.1%
11.80
29,500 USD 		2,500 +22.1% 11.80 29,500 USD
2022-05-12 2022-05-10 B Purchase

Robbins Wendye

Non-Executive Director
2,000 +21.5%
10.54
21,080 USD 		2,000 +21.5% 10.54 21,080 USD
2022-05-12 2022-05-10 PP Planned purchase

Young Rodney KB

Chief Financial Officer

Officer
5,000 +98.3%
10.53
52,650 USD 		5,000 +98.3% 10.53 52,650 USD
2022-05-12 2022-05-10 B Purchase

COLUMN GROUP II, LP

Major owner
41,250 +inf%
10.67
440,199 USD 		41,250 +inf% 10.67 440,199 USD
2022-05-12 2022-05-10 B Purchase

COLUMN GROUP II, LP

Major owner
1,208,750 +inf%
10.67
12,899,176 USD 		1,208,750 +inf% 10.67 12,899,176 USD
2022-05-05 2022-05-04 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
720 -3.5%
15.05
10,836 USD 		720 -3.5% 15.05 10,836 USD
2022-04-12 2022-04-11 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,647 -11.8%
23.05
61,013 USD 		2,647 -11.8% 23.05 61,013 USD
2022-04-07 2022-04-06 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
3,000 -5.3%
22.96
68,880 USD 		3,000 -5.3% 22.96 68,880 USD
2022-03-14 2022-03-11 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,648 -11.8%
23.91
63,314 USD 		2,648 -11.8% 23.91 63,314 USD
2022-02-28 2022-02-28 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
3,000 -5.1%
18.79
56,370 USD 		3,000 -5.1% 18.79 56,370 USD
2022-02-14 2022-02-11 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,647 -11.8%
22.47
59,478 USD 		2,647 -11.8% 22.47 59,478 USD
2022-01-14 2022-01-13 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
3,000 -4.9%
30.67
92,010 USD 		3,000 -4.9% 30.67 92,010 USD
2022-01-13 2022-01-11 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,648 -11.8%
32.16
85,160 USD 		2,648 -11.8% 32.16 85,160 USD
2022-01-06 2022-01-05 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
2,000 -3.2%
40.00
80,000 USD 		2,000 -3.2% 40.00 80,000 USD
2021-12-13 2021-12-10 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,647 -11.8%
30.88
81,739 USD 		2,647 -11.8% 30.88 81,739 USD
2021-12-06 2021-12-03 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
3,000 -5.0%
32.26
96,780 USD 		3,000 -5.0% 32.26 96,780 USD
2021-12-10 2021-11-11 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,648 -11.8%
35.69
94,507 USD 		2,648 -11.8% 35.69 94,507 USD
2021-10-19 2021-10-18 B Purchase

Robbins Wendye

Non-Executive Director
500 +5.7%
30.70
15,350 USD 		500 +5.7% 30.70 15,350 USD
2021-10-15 2021-10-13 B Purchase

Robbins Wendye

Non-Executive Director
400 +4.8%
29.69
11,876 USD 		400 +4.8% 29.69 11,876 USD
2021-10-14 2021-10-13 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
3,000 -4.8%
29.69
89,070 USD 		3,000 -4.8% 29.69 89,070 USD
2021-10-12 2021-10-11 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,647 -11.8%
30.78
81,475 USD 		2,647 -11.8% 30.78 81,475 USD
2021-09-29 2021-09-27 S Sale

COLUMN GROUP II, LP

Major owner
625 -100.0%
34.94
21,840 USD 		625 -100.0% 34.94 21,840 USD
2021-09-29 2021-09-27 S Sale

COLUMN GROUP II, LP

Major owner
1,114 -100.0%
34.97
38,951 USD 		1,114 -100.0% 34.97 38,951 USD
2021-09-29 2021-09-27 S Sale

COLUMN GROUP II, LP

Major owner
7,500 -100.0%
34.48
258,606 USD 		7,500 -100.0% 34.48 258,606 USD
2021-09-14 2021-09-13 S Sale

COLUMN GROUP II, LP

Major owner
4,788 -11.6%
35.28
168,942 USD 		4,788 -11.6% 35.28 168,942 USD
2021-09-14 2021-09-13 S Sale

COLUMN GROUP II, LP

Major owner
4,726 -6.1%
35.27
166,692 USD 		4,726 -6.1% 35.27 166,692 USD
2021-09-14 2021-09-13 S Sale

COLUMN GROUP II, LP

Major owner
4,803 -6.2%
35.25
169,309 USD 		4,803 -6.2% 35.25 169,309 USD
2021-09-14 2021-09-10 S Sale

COLUMN GROUP II, LP

Major owner
7,231 -14.9%
35.19
254,494 USD 		7,231 -14.9% 35.19 254,494 USD
2021-09-14 2021-09-10 S Sale

COLUMN GROUP II, LP

Major owner
7,320 -8.7%
35.19
257,573 USD 		7,320 -8.7% 35.19 257,573 USD
2021-09-14 2021-09-10 S Sale

COLUMN GROUP II, LP

Major owner
7,187 -8.5%
35.19
252,940 USD 		7,187 -8.5% 35.19 252,940 USD
2021-09-13 2021-09-10 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,648 -11.8%
35.78
94,745 USD 		2,648 -11.8% 35.78 94,745 USD
2021-06-21 2021-06-16 B Purchase

Robbins Wendye

Non-Executive Director
5 +1.7%
31.61
158 USD 		5 +1.7% 31.61 158 USD
2021-06-21 2021-06-16 B Purchase

Robbins Wendye

Non-Executive Director
100 +1.5%
31.53
3,153 USD 		100 +1.5% 31.53 3,153 USD
2021-06-21 2021-06-16 B Purchase

Robbins Wendye

Non-Executive Director
100 +1.5%
31.56
3,156 USD 		100 +1.5% 31.56 3,156 USD
2021-06-21 2021-06-16 B Purchase

Robbins Wendye

Non-Executive Director
500 +8.2%
31.54
15,770 USD 		500 +8.2% 31.54 15,770 USD
2021-06-17 2021-06-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.7%
43.26
43,260 USD 		1,000 -1.7% 43.26 43,260 USD
2021-06-15 2021-06-11 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,647 -11.8%
18.55
49,102 USD 		2,647 -11.8% 18.55 49,102 USD